Go to Home
 
about us
registration
online forum
resources
mission statement
events
related links
 

Spring 2009 update

  • A message from the President
  • Seminar - Corneal crosslinking: how safe and effective is it really?
  • Keratoconus and allergies
  • Update on CERA corneal crosslinking trial
  • Latest seminar videos
  • Volunteers flock to Melbourne optometrist training clinics
  • Organ Donation Awareness
  • Action on contact lenses
  • Support work
  • Useful Australian eye health and other health-related sites
  • Other Association news
  • Articles on the Net
  • Research - NSW stem cell breakthrough & keratoconus


    A MESSAGE FROM THE PRESIDENT

    Welcome to this latest news update. Its been a while. Our apologies. Often we barely have time to do those things that seem essential and it can be hard to let you know about the good work the committee is doing on behalf of members and supporters.

    Please contact us with any suggestions about how we can best keep in touch with you about KA activities. Also please send us any items of interest you would like to share with other KA members.


    We
    require help on a number of other projects. Contact us if you want to lend a hand.

    All the best

    Larry Kornhauser


    DEMYSTIFYING KERATOCONUS SEMINARS

    Corneal crosslinking: how safe and effective is it really?
    (August 5, 2009)

  • The Association held a public seminar on corneal crosslinking in early August. Some 60 patients and their families, optometrists and ophthalmologists heard presentations by Associate Professor Grant Snibson, chief investigator of the CERA crosslinking trial in Melbourne, and Dr Christine Wittig who is assisting him.

    Dr Wittig explained the trial and outlined the results to date (see below). These indicate that the treatment has proved both safe and effective in halting progression of keratoconus in the patients treated over the past three years since the start of the trial.

    Joanne Brooks, a teacher and artist and the first patient treated in the trial, described what motivated her to join the trial and her experiences since. Her lively presentation provided a useful patient perspective on corneal collagen crosslinking and on what patients and their families should expect from the treatment.

    Assoc. Prof. Snibson then attempted to grapple with the hard questions surrounding the treatment: who should consider it, when, and where the operation should be performed. He also discussed the different types of crosslinking being offered by corneal surgeons today and some of the "extras" also being proposed. Finally, he explained who shouldn't have the treatment and why.

    The presentations were followed by a Q&A session which allowed attendees an opportunity to raise other issues of concern.

    We strongly recommend the video of this seminar to anyone considering corneal collagen crosslinking for themselves or a family member. Details of how to purchase the seminar DVD, now available, can be found on the video page.

    return to menu

    line
    KERATOCONUS AND ALLERGIES


    blockThe arrival of spring means warmer weather and longer days. But for many people with keratoconus it also heralds the return of allergies: hayfever, asthma and itchy eyes that can make life hell for those of us who wear contact lenses.

    Keratoconus can be aggravated by eye rubbing. So if you suffer from itchy eyes, please see your chemist, GP or optometrist to obtain some of the excellent eye drops that can provide relief at this time of year. If you also have hayfever, a general antihistamine tablet may be a better alternative. Chronic sufferers should see an allergist to explore ways of achieving long term relief and control of their allergies and asthma.

    For problems with dry eye, consider using a rewetting agent on your contact lenses. Again your contact lens fitter should be able to advise on a strategy for managing the problem.

  • If you suffer from either condition, it is vital not to rub your eyes and to seek treatment from an experienced keratoconus practitioner to ensure that your contact lenses do not damage your corneas. Rubbing your eyes may feel good, but it also encourages you to continue and risk further progression in your keratoonus.


    block
    UPDATE ON CERA CORNEAL CROSSLINKING TRIAL

    blockThe Centre for Eye Research Australia (CERA) in Melbourne has provided the Association with an update on its corneal collagen crosslinking trial. Started in 2006, the CERA trial was the world's first randomized clinical trial of corneal crosslinking and is being followed closely by corneal surgeons and keratoconus patients in Australia and overseas.

    Key Findings

  • Although results varied in the first 3-6 months, after 12 months all patients who received the crosslinking treatment showed stabilization in their keratoconus at their pre-treatment level.

  • Some patients even experienced a mild flattening in their cornea.

    Volunteers required for "thin cornea" pilot study
  • CERA is also conducting a pilot study of crosslinking for patients with corneas with a thickness of less than 400 microns.

    Patients who are interested in participating in the ‘thin cornea’ pilot study or in being assessed for a placement on the waiting list are advised to contact their eye care specialist or Trial Coordinator Tony Ngo on 03 9929 8618 or via email at tonyn@unimelb.edu.au

    Funding is urgently required for both current and future studies. Please contact Tony Ngo (details above) if you can assist.

  • The full update can be downloaded in pdf format here.

    Other Crosslinking News
  • Many members are requesting information about corneal crosslinking and where they can find a corneal surgeon to perform the operation. We can help you find a centre which performs crosslinking. But we remind all keratoconus patients that this is not a risk-free treatment and should be performed by a corneal surgeon who has experience in treating keratoconus.

    return to menu


    VIDEOS OF KA SEMINARS

    Videos
    now available

  • Corneal Collagen Crosslinking: how safe and effective is it really?
    by Associate Professor Grant Snibson, Dr Christine Wittig-Silva, Joanne Brooks
  • New contact lenses and a patient's view of corneal collagen crosslinking
    by Richard Lindsay and Anslie Fitzsimons.
    Free audio podcasts of these presentations can be found here.
  • All previous seminars held by the Association are also available.
    For details go to the video page.


    return to menu


    KA MEMBERS SUPPORT OPTOMETRIST TRAINING CLINICS
    (Melbourne - September 30 - October 28)

    Once again, Keratoconus Australia members responded positively to our call for volunteers for the special keratoconus clinics organized by Melbourne optometrist Associate Professor Richard Vojlay and Melbourne University's Department of Optometry and Vision Sciences for final year optometry students.These clinics are structured to teach students more about keratoconus, the concerns of patients and in particular, how best to fit contact lenses on keratoconic eyes and corneal transplants. Thanks to the participation of KA members, students were again able to attempt contact lens fits on a wide range of keratoconic and post graft corneas. KA members attending the post-graft clinics were able to take advantage of the presence of AP Vojlay and optomistrist Laura Downey to obtain some tips on how to improve their contact lens options.

    The clinics have been extremely well received by the students and the Department of Optometry and Vision Sciences since they began three years ago.

    This year's special lecture on keratoconus for the final year student's was held on October 16 and was well attended by the final year students. Associate Professor Vojlay outlined the special problems raised by keratoconus, while KA President, Larry Kornhauser and KA Secretary Belinda Cerritelli, described the issues commonly facing patients and their families when dealing with keratoconus. The lecture concluded with a lively Q&A session which tested the students' ability to deal with real life situations.

    return to menu



    ORGAN DONATION AWARENESS

    Keratoconus Australia supports organ donation by distributing brochures for the Australian Organ Donation Register to all new members. We encourage all members to discuss this important issue with friends and family, who can register as organ donors. Should you require more information about organ donation and the register, go to Australian Organ Donor Register

    return to menu


    ACTION ON CONTACT LENSES

    Keratoconus Australia continues to press for action to lower the cost of specialized contact lenses for keratoconus. Details of recent and past efforts in this regard can be found on our Action on Contact Lenses page.

  • But that could take time. So in the meantime, we suggest members put pressure on their private health funds to recognize the special nature of contact lenses for keratoconus and to provide higher rebates on claims for these specialized and indispensable lenses.

    With the assistance of the US Keratoconus Foundation, we have prepared a letter which members can download and print to send along with their contact lens claims to their private health fund. Please send this letter to your health fund EVERY TIME you submit a claim for a rebate on your new contact lenses.
    Letter to request a higher rebate from your health fund (in pdf format)

  • Latest initiatives
    KA attended the July 2 meeting of Vision2020 Australia's Low Vision & Rehabilitation Working Group to secure backing from affiliated membe
    rs for our campaign to lower the cost of contact lenses for keratoonus. A vote taken at the meeting endorsed the KA initiative and authorized Vision2020 to provide ongoing support to KA.

    Since then, Belinda and Larry have had talks with various representatives of optometrist groups in a bid to advance this issue. We will report back as developments occur.

  • Other contact lens news
    SynergEyes,
    a new hybrid contact lens for keratoconus, has finally arrived in Australia. These lenses offer a level of comfort to advanced keratoconus patients which is not always achievable with normal rigid gas permeable lenses. They have been used successfully overseas to fit patients who might have otherwise required a corneal transplant. Unfortunately they are very expensive, need to be replaced regularly (every 6-12 months) and can be tricky to fit. Post-graft lenses have not been very successful to date. Information about the lenses can be found here (warning: this is advertising material).

    As they need to be ordered from the US, the manufacturer is supplying them only to a limited number of contact lens fitters around Australia. If your contact lens fitter does not have access to these lenses, please contact us and will we try to assist you in finding a local provider.

    return to menu


    SUPPORT WORK
  • blockKeratoconus Australia has provided support to over 140 people since the start of 2009. This support has taken various forms including:

    • assistance in finding eye-carers experienced in fitting contact lenses for keratoconus and performing corneal transplants and corneal crosslinking (CXL)

    • counselling for people before and after corneal transplants and CXL

    • distribution of information about keratoconus, contact lenses, CXL and corneal transplants

    • providing advice about contact lenses

    • providing information about intacs and other surgical procedures

    • connecting families with adolescents facing surgery or dealing with other keratoconus-related issues

    Support work is done with the kind assistance of a group of optometrists and ophthalmologists who provide technical and medical advice in response to members' queries.

    You can obtain support by ringing us on 0409 644 811 or emailing questions via the Online Forum

    (Please note that suppport will be limited from December 21, 2009 to January 25, 2010).

    return to menu


    USEFUL AUSTRALIAN HEALTH LINKS

    This page on the Department of Health and Aging website provides links to a number of organizations which could help you negotiate the complexities of the Australian health system. Included are:

  • Department of Health and Ageing - Eye Health Page
  • Medicare Australia
  • Private Health Insurance Ombudsman

    Other useful links
  • Australian Competition and Consumer Commission (ACCC)
  • Consumers' Health Forum of Australia (CHF)

    return to menu


    KA COMMITTEE NOTES

    blockThe committee has been busy organizing events, promoting the Association and its work and assisting people with keratoconus and their families in many ways.

    The committee meets on a regular basis. Please contact us if you would like further details or you would like to assist in a current or future project.

    We are still looking for enthusiastic people to join the committee and bring new ideas about how we can expand and develop the Association's activities.

    Membership

    The Association currently has some 1,420 full members. That is an increase of over 11% since the Annual General Meeting held in November 2008.

    return to menu


    ON the NET

    blockBelow are links to some articles and research of interest to keratoconus patients. Please send us any information you find so that we can share it with others.

    (Disclaimer: Keratoconus Australia Inc takes no responsibility for information found on off-site links. This information is outside the control of the association and it remains the responsibility of internet users to evaluate its accuracy.)

    Corneal Collagen Crosslinking

  • VIDEO Corneal Crosslinking for Keratoconus An excellent animated description of keratoconus and the crosslinking procedure by a French team headed by Dr David Touboul. Detailed and targeted at ophthamologists. (real player required)

  • Cataract & Refractive Surgery Today Europe published a corneal crosslinking special edition in April 2009 which examined a range of issues relating to CXL. These include the impact of crosslinking, patient selection criteria, the aging effect on the cornea and its use with other surgery.

  • Contact Lens Spectrum has three articles of interest for keratoconus patients in its September 2009 edition.



  • Ocular Surgery News Supersite has regular news updates from around the world. Also covers developments in contact lenses.

  • The US National Keratoconus Foundation publishes a regular newsletter which includes articles on a range of keratoconus topics, stories about living with keratoconus and FAQ's answered by their consulting optometrist.

    Articles in the winter 2009 edition include:
  • Scleral Lenses and Keratoconus
  • Does Keratoconus Recur After Corneal Transplantation?
  • Corneal Collagen Cross-Linking

    return to menu

    line
    RESEARCH


    blockThe Association continues to involve itself in a number of research initiatives relating to keratoconus. Contact us for further details or if you are interested in funding a project.

  • NSW Uni stem cell breakthrough & keratoconus
    A number of members have contacted the Association about the University of NSW's use of stem cells on contact lenses to restore sight to people suffering from corneal damage. In particular, members have asked if this procedure can be used to halt progression in keratoconus or reverse damage from the condition.

    The simple answer is "no" at this stage. The NSW procedure (outlined here) affects only the very outer layer of the cornea (the epithelium) and not the stroma which is affected by keratoconus. The researchers tell Keratoconus Australia they are looking at ways to use the procedure to repair and strengthen the stroma - but clinical trials could be still years away.

    Dr Stephanie Watson, a member of the UNSW team, had this to say about the procedure and keratoconus:
  • Our treatment only replenishes the very first layer of the cornea, the
    epithelium. This layer is like the skin of the eye. In keratoconus it is the
    middle section of the cornea, the stroma, that is abnormal. A different set
    of stem cells looks after this part of the cornea so it is these cells that
    need to be replenished not the surface layer. Our lab is investigating these cells but our findings are not ready for clinical application yet.


    return to menu

    line